Patents by Inventor David Hollenback

David Hollenback has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • LPAAT-beta inhibitors and uses thereof
    Publication number: 20070072856
    Abstract: The invention relates to triazines and the use thereof to inhibit lysophosphatidic acid acyltransferase ? (LPAAT-?) activity. The invention further relates to methods of treating cancer using said triazines. The invention also relates to methods for screening for LPAAT-? activity.
    Type: Application
    Filed: November 16, 2006
    Publication date: March 29, 2007
    Applicant: Cell Therapeutics, Inc.
    Inventors: Baoqing Gong, John Tulinsky, Lynn Bonham, J. Klein, Robert Finney, David Hollenback, Scott Shaffer, Norina Tang, Thayer White, David Leung
  • Human lysophosphatidic acid acyltransferase gamma-1 polypeptide
    Publication number: 20060211102
    Abstract: Polypeptides are obtained, for example, via expression of encoding cDNA sequences, that have the activity of the enzyme lysophosphatidic acid acyltransferase (LPAAT), also known as 1-acyl sn-glycerol-3-phosphate acyltransferase.
    Type: Application
    Filed: May 25, 2006
    Publication date: September 21, 2006
    Inventors: David Leung, Daniel Adourel, David Hollenback
  • Human lysophoshatidic acid acyltransferase gamma-1 polypeptide
    Patent number: 7052891
    Abstract: Polypeptides are obtained, for example, via expression of encoding cDNA sequences, that have the activity of the enzyme lysophosphatidic acid acyltransferase (LPAAT), also known as 1-acyl sn-glycerol-3-phosphate acyltransferase.
    Type: Grant
    Filed: September 23, 2003
    Date of Patent: May 30, 2006
    Assignee: Cell Therapeutics Inc.
    Inventors: David W. Leung, Daniel Adourel, David Hollenback
  • Human lysophosphatidic acid acyltransferase gamma-2 polypeptide
    Patent number: 7045327
    Abstract: Polypeptides are obtained, for example, via expression of encoding cDNA sequences, that have the activity of the enzyme lysophosphatidic acid acyltransferase (LPAAT), also known as 1-acyl sn-glycerol-3-phosphate acyltransferase.
    Type: Grant
    Filed: September 23, 2003
    Date of Patent: May 16, 2006
    Assignee: Cell Therapeutics Inc.
    Inventors: David W. Leung, Daniel Adourel, David Hollenback
  • LPAAT-beta inhibitors and uses thereof
    Publication number: 20060035896
    Abstract: The invention relates to triazines and the use thereof to inhibit lysophosphatidic acid acyltransferase ? (LPMT-?) activity. The invention further relates to methods of treating cancer using said triazines. The invention also relates to methods for screening for LPAAT-? activity.
    Type: Application
    Filed: September 12, 2005
    Publication date: February 16, 2006
    Applicant: Cell Therapeutics, Inc.
    Inventors: Lynn Bonham, J. Klein, Robert Finney, David Hollenback, Scott Shaffer, Norina Tang, Thayer White, David Leung, Baoqing Gong, John Tulinsky
  • Method of screening compounds that inhibit lysophosphatidic acid acyltransferase
    Publication number: 20040086996
    Abstract: Polypeptides are obtained, for example, via expression of encoding cDNA sequences, that have the activity of the enzyme lysophosphatidic acid acyltransferase (LPAAT), also known as 1-acyl sn-glycerol-3-phosphate acyltransferase.
    Type: Application
    Filed: September 23, 2003
    Publication date: May 6, 2004
    Applicant: CELL THERAPEUTICS, INC.
    Inventors: David W. Leung, Daniel Adourel, David Hollenback
  • Method of screening compounds that inhibit lysophosphatidic acid acyltransferase
    Publication number: 20040082049
    Abstract: Polypeptides are obtained, for example, via expression of encoding cDNA sequences, that have the activity of the enzyme lysophosphatidic acid acyltransferase (LPAAT), also known as 1-acyl sn-glycerol-3-phosphate acyltransferase.
    Type: Application
    Filed: September 23, 2003
    Publication date: April 29, 2004
    Applicant: CELL THERAPEUTICS, INC.
    Inventors: David W. Leung, Daniel Adourel, David Hollenback
  • Method of screening compounds that inhibit lysophosphatidic acid acyltransferase
    Publication number: 20040043465
    Abstract: Polypeptides are obtained, for example, via expression of encoding cDNA sequences, that have the activity of the enzyme lysophosphatidic acid acyltransferase (LPAAT), also known as 1-acyl sn-glycerol-3-phosphate acyltransferase.
    Type: Application
    Filed: September 23, 2003
    Publication date: March 4, 2004
    Applicant: CELL THERAPEUTICS, INC.
    Inventors: David W. Leung, Daniel Adourel, David Hollenback
  • Method of screening compounds that inhibit lysophosphatidic acid acyltransferase
    Patent number: 6670143
    Abstract: Polypeptides are obtained, for example, via expression of encoding cDNA sequences, that have the activity of the enzyme lysophosphatidic acid acyltransferase (LPAAT), also known as 1-acyl sn-glycerol-3-phosphate acyltransferase.
    Type: Grant
    Filed: October 5, 2001
    Date of Patent: December 30, 2003
    Assignee: Cell Therapeutics, Inc.
    Inventors: David W. Leung, Daniel Adourel, David Hollenback
  • Mammalian lysophosphatidic acid acyltransferase
    Publication number: 20020156262
    Abstract: Polypeptides are obtained, for example, via expression of encoding cDNA sequences, that have the activity of the enzyme lysophosphatidic acid acyltransferase (LPAAT), also known as 1-acyl sn-glycerol-3-phosphate acyltransferase.
    Type: Application
    Filed: October 5, 2001
    Publication date: October 24, 2002
    Inventors: David W. Leung, Daniel Adourel, David Hollenback
  • Mammalian lysophosphatidic acid acyltransferase
    Patent number: 6300487
    Abstract: Polypeptides are obtained, for example, via expression of encoding cDNA sequences, that have the activity of the enzyme lysophosphatidic acid acyltransferase (LPAAT), also known as 1-acyl sn-glycerol-3-phosphate acyltransferase.
    Type: Grant
    Filed: December 18, 1998
    Date of Patent: October 9, 2001
    Assignee: Cell Therapuetics, Inc.
    Inventors: David W. Leung, Daniel Adourel, David Hollenback